Moreover, overexpression of E2F1 has been reported to be related to tumor growth and cell survival in prostate cancer (PCa), whereas knockdown treatment of E2F1 inhibited cell cycle progression, invasion, and migration of PCa cell lines in vitro, as well as tumor growth and EMT in vivo [38]. This evidence concerns the gene E2F1 and prostate carcinoma.